Oye Gureje, NNMA, FAS
MBBS, MSc, PhD, DSc, FRCPsych, FRANZCP, FMCPsych, FWACP
The poster should be formatted with the following headings Background, aims, methodology, results, discussion and conclusions
Physical Poster Size: 3ft wide and 4ft height (Portrait)
Online submission - Poster size: 10 in x 5.625 in (16:9) (Landscape)
Avoid crowding of text, data and figures. Illustrations and tables should be easily readable.
All sources of financial sponsorship of the study should be stated in the poster.
All poster submissions should be original work of the authors
Please submit full poster (abstract will not be accepted)
Previously published work (in any format) will not be accepted. The authors are requested to give an undertaking that the e-poster content has not been previously published or been submitted for publication elsewhere at the time of submission
All research posters are accepted with the understanding that the research has been approved by appropriate ethics bodies
All submitted posters will be screened for suitability by senior clinicians of SCARF
Authors will be informed by email the outcome of the screening
At least one of the authors should be a registered delegate of the conference if the poster is accepted for presentation
All posters will be displayed in the conference venue as physical posters. Authors will be provided the details of the day of the conference when the poster will be displayedat least 1 month before the conference
The author is expected to bring the physical poster and display in the designated area at the assigned time
The author is responsible for collecting the poster at the end of the display
All accepted posters will be considered for a poster competition
The poster competition will be judged by independent senior academicians
The posters will be judged on present criteria (novelty of theme, methodology and presentation style)
All displayed posters will be acknowledged with a certificate
The certificate of poster presentation will only be issued in the name of the first author
At least one author should be available in the poster presentation area to interact with the delegates and judges during the allotted time
MBBS, MSc, PhD, DSc, FRCPsych, FRANZCP, FMCPsych, FWACP
In 2018, we had initiated the Dr Sarada Menon Oration to honour Padma Bhushan, late Dr M Sarada Menon -Founder of the Schizophrenia Research Foundation. One of the very early women psychiatrists in India, she has been instrumental in the bringing visibility to Psychosocial Rehabilitation for persons with Serious Mental illness. Extensively involving families of persons with serious mental illnesses and the local community, she gave a new meaning to the concept of resource mobilization. Starting SCARF with many likeminded individuals 34 years ago, her vision was to advance research in the field of schizophrenia and feed this back into the medical and psychosocial management. Promoting awareness on mental health and illnesses was her approach to involve the local community to re-integrate mentally ill patients into the society.
A committed and passionate teacher, she has continued to mould mental health professions over several generations. In her mid-nineties, she still updates herself with the advancements in the field of Psychiatry.
As a tribute to the immense contributions of Dr Sarada Menon to the field of mental health, Prof. Oye Gureje, University of Ibadan, Nigeria will deliver the Dr Sarada Menon Oration.
Prof. Oye Gureje is the Director of the World Health Organization Collaborating Centre for Research and Training in Mental Health, Neurosciences, Drug and Alcohol Abuse in the institution. He has been active in global mental health for over two decades with leadership roles in several collaborative studies in epidemiology, randomized controlled trials and health system strengthening.
Globally, psychosis is a major cause of disease burden for affected persons, their families, and the society. However, important contextual differences exist in the pattern of the burden and the help seeking behaviour of people living with psychosis and their families. Thus, even though physical comorbidity is a common reason for the reduced life expectancy that is associated with psychosis, the profile of comorbidity in low- and middle-income countries may reflect interactions between psychopathology and prevailing social and economic adversities. Also, the care needs of affected persons may in part be shaped by cultural expectations that are not entirely determined by objective effectiveness of interventions. It is therefore important that efforts to deliver services that meet the needs of persons living with psychosis must be informed by a consideration of the context in which the condition occurs.
Oye Gureje is Professor of Psychiatry and Director, WHO Collaborating Centre for Research in Mental Health, Neurosciences and Substance Abuse, Department of Psychiatry, University of Ibadan. He is Chair of the Mental Health Action Committee of the Federal Ministry of Health and a member of the Ministerial Expert Advisory Committee on COVID-19. Among many other previous roles, he was a member of the WHO International Advisory Group for ICD Revision and chaired the Work Groups on Somatic Distress and Dissociative Disorders as well as of Cultural Guidance for ICD-11. He has also been a Board Member of the World Psychiatric Association, Chair of the Task Force on Brain Drain, as well as serving in other leadership roles, including currently as a member of the Action Working Group on Comorbidity. His main research interests are in epidemiology and global mental health. He has conducted large scale community-based surveys, large randomized controlled trials, implementation research and research on health system strengthening with grant supports from the Welcome Trust, MRC (UK), EU, AusAid, Grand Challenges Canada, IDRC and the NIMH, among others. He has published more than 500 peer-reviewed scientific papers, monographs, book chapters, and has co-edited 3 books and has, for several years, been listed among the global highly cited researchers by Clarivate Analytics. A recipient of many awards, he is a Fellow of the Nigerian Academy of Science, Fellow of the Nigerian Academy of Medicine, and a laureate of the Nigerian National Order of Merit, the country’s highest honor for academic achievement.
SCARF welcomes all the eminent psychiatrists, scientists, academicians, young researchers, and other mental health professionals from all over the world to attend the signature event of this year the 10th International Conference on Schizophrenia by SCARF India in Chennai from August 25th to 27th, 2022.
IConS of SCARF is a biennial event providing an interactive environment, where researchers from all over the world would meet, talk about and discuss developments in the field of Schizophrenia and related areas. Delegates will have opportunities to explore new emerging grounds in the field and a fertile ground for enhancing their knowledge.
The theme for this year of IConS is "Exploring links between research and interventions in Psychoses"
The 3 day conference will feature pre-conference workshops, plenary talks, and symposia. The prestigious Dr. Sarada Menon Oration will be in its 4th Edition Young Researchers get an opportunity to present their research endeavors by participating in the Young Researcher award All delegate can showcase their work through poster presentations.
We are looking forward to meeting you in person for a conference sharing new and exciting results.
Anna Nagar (West Extn.),
Chennai 600 101, India